Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori

American Journal of Gastroenterology

Volumn 92, Issue 1, 1997, Pages 84-88

  Furuta, Takahisa ^a   Kaneko, Eizo ^a   Baba, Satoshi ^a   Arai, Hajime ^a   Futami, Hajime ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; LANSOPRAZOLE; PEPSINOGEN I; PEPSINOGEN II; UREASE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BLOOD LEVEL; ENDOSCOPIC BIOPSY; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SERUM; STOMACH BIOPSY; STOMACH JUICE; TREATMENT FAILURE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PEPSINOGENS; STOMACH ULCER;

EID: 0031012979     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation J Infect Dis 1990;161:626-33.
2. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720-7.
3. Mooney C, Keenan J, Munster D, et al. Neutrophil activation by Helicobacter pylori. Gut 1991;32:853-7.
4. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615-25.
5. Marshall BJ, Goodwin CS, Warren Jr, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;1:1437-42.
6. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
7. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-31.
8. Asaka M, Kato M, Kudo M, et al. The role of Helicobacter pylori in peptic ulcer disease. Gastroenterol Jpn 1993;28(suppl 5):163-7.
9. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
10. Hunter FM, Correa P, Fontham E, et al. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 1993;38:2081-6.
11. Chen TS, Tsay SH, Chang FY, et al. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: A 12-month follow-up study. Am J Gastroenterol 1994; 89:1511-4.
12. Chittajallu RS, Dorrian CA, Ardill JES, et al. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol 1992;27:20-4.
13. Furuta T, Futami H, Arai H, et al. Effects of lansoprazole with or without amoxicillin on ulcer healing: Relation to eradication of Helicobacter pylori. J Clin Gastroenterol 1995;20(suppl 2):S107-11.
14. Furuta T, Kaneko E, Suzuki M, et al. Quantitative study of Helicobacter pylori in gastric mucus by competitive PCR using synthetic DNA fragments. J Clin Microbiol 1996;34:2421-5.
15. Dent JC, McNulty CA. Evaluation of a new selective medium for Campylobacter pylori. Eur J Clin Microbiol Infect Dis 1988;7:555-8.
16. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. The Sydney system: A new classification of gastritis. Working Party Reports. Sydney: World Congress of Gastroenterology, 1990:1-10.
17. Rauws EAJ, Langenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active gastritis. A prospective study of its prevalence and the effects of antibacterial and anti-ulcer treatment. Gastroenterology 1988;94:33-40.
18. Wang WM, Chen CY, Jan CM, et al. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer. Am J Gastroenterol 1994;89:1793-6.
19. Hirsch AM, Brandstatter G, Dragosics B, et al. Kinetics of specific antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993;168:763-6.
20. Sipponen P, Samloff IM, Saukkonen M, et al. Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy. Gut 1985; 26:1179-82.